Offerings Archives - Page 64 of 166

2 minute read

DiaMedica Therapeutics Announces $37.5M Private Placement Of 11,011,406 Common Shares At A Purchase Price Of $3.40/Share

June 21, 8:42 AM

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases ("DiaMedica" or the

DMAC

1 minute read

CBRE Prices $1B Senior Notes Offering, Plans Debt Reduction From Proceeds

By Lekha Gupta

June 21, 5:45 AM

CBRE Group Inc (NYSE: CBRE) disclosed the pricing of a $1 billion senior notes

CBRE

1 minute read

Why Dragonfly Energy Shares Are Plunging Today

By Shivani Kumaresan

June 20, 11:35 AM

Dragonfly Energy Holdings Corp (NASDAQ: DFLI) has priced its underwritten public offering of 10 million shares and investor warrants to purchase up to an

DFLI

1 minute read

Dragonfly Energy Announces Pricing Of $20M Underwritten Public Offering Of 10M Shares Of Common Stock At A Price Of $2/Share

By Happy Mohamed

June 20, 9:06 AM

Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) ("Dragonfly Energy" or the "Company"), an industry leader in energy storage and producer of deep cycle lithium-ion storage batteries, today announced the

DFLI

1 minute read

Clene’s CNM-Au8 Shows Significant Reduction In Neurodegenerative Biomarker, Raises $40M Via Equity

By Vandana Singh

June 16, 1:55 PM

Clene Inc (NASDAQ: CLNN) reported new data demonstrating a statistically significant reduction of plasma neurofilament light chain (NfL) levels for CNM-Au8 treated participants compared to placebo after 24 weeks

CLNN

1 minute read

Applied UV Plunges After $5M Equity Offering

By Shivani Kumaresan

June 16, 10:22 AM

Applied UV Inc (NASDAQ: AUVI) has

AUVI

1 minute read

Applied UV Announces Pricing Of $5M Underwritten Public Offering Of 5M Shares Of Common Stock And Pre-Funded Warrants At A Price Of $1/Share

By Benzinga Newsdesk

June 16, 8:46 AM

Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), a global leading provider of advanced food security and air and surface disinfection technology, announced the pricing of its underwritten public offering

AUVI

1 minute read

CORRECTION: Panbela Announces Pricing Of ~$8.5M Public Offering Of 2.27M Shares Of Common Stock Or Pre-Funded Warrants In Lieu Thereof And Two Classes Of Warrants To Purchase Up To An Aggregate Of 4.54M Shares Of Its Common Stock At A Price Of $3.75/Sh…

By Benzinga Newsdesk

June 16, 8:23 AM

Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the pricing of a

PBLA

1 minute read

Panbela Announces Pricing Of ~$8.5M Public Offering Of 2.27M Shares Of Common Stock Or Pre-Funded Warrants In Lieu Thereof And Two Classes Of Warrants To Purchase Up To An Aggregate Of 4.54M Shares Of Its Common Stock At A Price Of $3.75/Share And Asso…

By Benzinga Newsdesk

June 16, 8:17 AM

Panbela Therapeutics, Inc.

PBLA

1 minute read

Verastem Oncology Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants; No Terms Disclosed

By Benzinga Newsdesk

June 15, 4:00 PM

Verastem Oncology, (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and pre-funded

VSTM